ID   K1C19_RAT               Reviewed;         403 AA.
AC   Q63279; A0JN08; Q5M7V2; Q6S6J4; Q9Z253;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   30-AUG-2005, sequence version 2.
DT   29-MAY-2024, entry version 164.
DE   RecName: Full=Keratin, type I cytoskeletal 19;
DE   AltName: Full=Cytokeratin-19;
DE            Short=CK-19;
DE   AltName: Full=Keratin-19;
DE            Short=K19;
DE   AltName: Full=Type I keratin Ka19;
GN   Name=Krt19; Synonyms=Ka19, Krt1-19;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], INTERACTION WITH DMD, AND TISSUE SPECIFICITY.
RC   TISSUE=Heart muscle;
RX   PubMed=15247274; DOI=10.1074/jbc.m400128200;
RA   Ursitti J.A., Lee P.C., Resneck W.G., McNally M.M., Bowman A.L.,
RA   O'Neill A., Stone M.R., Bloch R.J.;
RT   "Cloning and characterization of cytokeratins 8 and 19 in adult rat
RT   striated muscle. Interaction with the dystrophin glycoprotein complex.";
RL   J. Biol. Chem. 279:41830-41838(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Brown Norway;
RX   PubMed=15057822; DOI=10.1038/nature02426;
RA   Gibbs R.A., Weinstock G.M., Metzker M.L., Muzny D.M., Sodergren E.J.,
RA   Scherer S., Scott G., Steffen D., Worley K.C., Burch P.E., Okwuonu G.,
RA   Hines S., Lewis L., Deramo C., Delgado O., Dugan-Rocha S., Miner G.,
RA   Morgan M., Hawes A., Gill R., Holt R.A., Adams M.D., Amanatides P.G.,
RA   Baden-Tillson H., Barnstead M., Chin S., Evans C.A., Ferriera S.,
RA   Fosler C., Glodek A., Gu Z., Jennings D., Kraft C.L., Nguyen T.,
RA   Pfannkoch C.M., Sitter C., Sutton G.G., Venter J.C., Woodage T., Smith D.,
RA   Lee H.-M., Gustafson E., Cahill P., Kana A., Doucette-Stamm L.,
RA   Weinstock K., Fechtel K., Weiss R.B., Dunn D.M., Green E.D.,
RA   Blakesley R.W., Bouffard G.G., De Jong P.J., Osoegawa K., Zhu B., Marra M.,
RA   Schein J., Bosdet I., Fjell C., Jones S., Krzywinski M., Mathewson C.,
RA   Siddiqui A., Wye N., McPherson J., Zhao S., Fraser C.M., Shetty J.,
RA   Shatsman S., Geer K., Chen Y., Abramzon S., Nierman W.C., Havlak P.H.,
RA   Chen R., Durbin K.J., Egan A., Ren Y., Song X.-Z., Li B., Liu Y., Qin X.,
RA   Cawley S., Cooney A.J., D'Souza L.M., Martin K., Wu J.Q.,
RA   Gonzalez-Garay M.L., Jackson A.R., Kalafus K.J., McLeod M.P.,
RA   Milosavljevic A., Virk D., Volkov A., Wheeler D.A., Zhang Z., Bailey J.A.,
RA   Eichler E.E., Tuzun E., Birney E., Mongin E., Ureta-Vidal A., Woodwark C.,
RA   Zdobnov E., Bork P., Suyama M., Torrents D., Alexandersson M., Trask B.J.,
RA   Young J.M., Huang H., Wang H., Xing H., Daniels S., Gietzen D., Schmidt J.,
RA   Stevens K., Vitt U., Wingrove J., Camara F., Mar Alba M., Abril J.F.,
RA   Guigo R., Smit A., Dubchak I., Rubin E.M., Couronne O., Poliakov A.,
RA   Huebner N., Ganten D., Goesele C., Hummel O., Kreitler T., Lee Y.-A.,
RA   Monti J., Schulz H., Zimdahl H., Himmelbauer H., Lehrach H., Jacob H.J.,
RA   Bromberg S., Gullings-Handley J., Jensen-Seaman M.I., Kwitek A.E.,
RA   Lazar J., Pasko D., Tonellato P.J., Twigger S., Ponting C.P., Duarte J.M.,
RA   Rice S., Goodstadt L., Beatson S.A., Emes R.D., Winter E.E., Webber C.,
RA   Brandt P., Nyakatura G., Adetobi M., Chiaromonte F., Elnitski L.,
RA   Eswara P., Hardison R.C., Hou M., Kolbe D., Makova K., Miller W.,
RA   Nekrutenko A., Riemer C., Schwartz S., Taylor J., Yang S., Zhang Y.,
RA   Lindpaintner K., Andrews T.D., Caccamo M., Clamp M., Clarke L., Curwen V.,
RA   Durbin R.M., Eyras E., Searle S.M., Cooper G.M., Batzoglou S., Brudno M.,
RA   Sidow A., Stone E.A., Payseur B.A., Bourque G., Lopez-Otin C., Puente X.S.,
RA   Chakrabarti K., Chatterji S., Dewey C., Pachter L., Bray N., Yap V.B.,
RA   Caspi A., Tesler G., Pevzner P.A., Haussler D., Roskin K.M., Baertsch R.,
RA   Clawson H., Furey T.S., Hinrichs A.S., Karolchik D., Kent W.J.,
RA   Rosenbloom K.R., Trumbower H., Weirauch M., Cooper D.N., Stenson P.D.,
RA   Ma B., Brent M., Arumugam M., Shteynberg D., Copley R.R., Taylor M.S.,
RA   Riethman H., Mudunuri U., Peterson J., Guyer M., Felsenfeld A., Old S.,
RA   Mockrin S., Collins F.S.;
RT   "Genome sequence of the Brown Norway rat yields insights into mammalian
RT   evolution.";
RL   Nature 428:493-521(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-123.
RC   STRAIN=Wistar;
RA   Appert A., Perlman S., Cate R., Laverriere J.N., Vigier B., Magre S.;
RT   "Sex-dependent expression of keratin 19 in differentiating fetal rat
RT   gonads. Repressive effect of anti-Mullerian hormone on K19 gene
RT   transcription.";
RL   Submitted (SEP-1998) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 114-368, TISSUE SPECIFICITY, AND
RP   DEVELOPMENTAL STAGE.
RC   STRAIN=Wistar;
RX   PubMed=8541209; DOI=10.1016/0925-4773(95)00401-l;
RA   Fridmacher V., le Bert M., Guillou F., Magre S.;
RT   "Switch in the expression of the K19/K18 keratin genes as a very early
RT   evidence of testicular differentiation in the rat.";
RL   Mech. Dev. 52:199-207(1995).
RN   [6]
RP   PROTEIN SEQUENCE OF 94-100 AND 163-169, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Hippocampus;
RA   Lubec G., Diao W., Chen W.-Q.;
RL   Submitted (APR-2007) to UniProtKB.
RN   [7]
RP   GENE MODEL.
RX   PubMed=15085952; DOI=10.1078/0171-9335-00354;
RA   Hesse M., Zimek A., Weber K., Magin T.M.;
RT   "Comprehensive analysis of keratin gene clusters in humans and rodents.";
RL   Eur. J. Cell Biol. 83:19-26(2004).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-27; SER-35; SER-40; SER-57
RP   AND SER-67, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Involved in the organization of myofibers. Together with
CC       KRT8, helps to link the contractile apparatus to dystrophin at the
CC       costameres of striated muscle (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Heterotetramer of two type I and two type II keratins.
CC       Interacts with PNN (By similarity). Interacts with the actin-binding
CC       domain of DMD. {ECO:0000250, ECO:0000269|PubMed:15247274}.
CC   -!- INTERACTION:
CC       Q63279; P11530: Dmd; NbExp=3; IntAct=EBI-876985, EBI-706166;
CC   -!- TISSUE SPECIFICITY: Expressed in brain, heart, skin and in costameres
CC       of myoplasm at the sarcolemmal membrane in skeletal and cardiac muscle
CC       fibers. Undifferentiated gonads and somatic cells of ovarian cords
CC       throughout the fetal ovary development. {ECO:0000269|PubMed:15247274,
CC       ECO:0000269|PubMed:8541209}.
CC   -!- DEVELOPMENTAL STAGE: Found in somatic cells of ovarian cords throughout
CC       the fetal ovary development. {ECO:0000269|PubMed:8541209}.
CC   -!- DOMAIN: This keratin differs from all other IF proteins in lacking the
CC       C-terminal tail domain.
CC   -!- MISCELLANEOUS: There are two types of cytoskeletal and microfibrillar
CC       keratin: I (acidic; 40-55 kDa) and II (neutral to basic; 56-70 kDa).
CC   -!- SIMILARITY: Belongs to the intermediate filament family.
CC       {ECO:0000255|PROSITE-ProRule:PRU01188}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH88424.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY464140; AAR36876.1; -; mRNA.
DR   EMBL; AABR03073341; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC088424; AAH88424.1; ALT_INIT; mRNA.
DR   EMBL; BC126075; AAI26076.1; -; mRNA.
DR   EMBL; AH006934; AAC64402.1; -; Genomic_DNA.
DR   EMBL; X81449; CAA57205.1; -; mRNA.
DR   EMBL; BK004046; DAA04480.1; -; mRNA.
DR   RefSeq; NP_955792.1; NM_199498.2.
DR   AlphaFoldDB; Q63279; -.
DR   SMR; Q63279; -.
DR   BioGRID; 262079; 1.
DR   IntAct; Q63279; 3.
DR   STRING; 10116.ENSRNOP00000019133; -.
DR   GlyGen; Q63279; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q63279; -.
DR   PhosphoSitePlus; Q63279; -.
DR   jPOST; Q63279; -.
DR   PaxDb; 10116-ENSRNOP00000019133; -.
DR   Ensembl; ENSRNOT00000019133.5; ENSRNOP00000019133.3; ENSRNOG00000003899.8.
DR   Ensembl; ENSRNOT00060055676; ENSRNOP00060046039; ENSRNOG00060032144.
DR   GeneID; 360626; -.
DR   KEGG; rno:360626; -.
DR   UCSC; RGD:619936; rat.
DR   AGR; RGD:619936; -.
DR   CTD; 3880; -.
DR   RGD; 619936; Krt19.
DR   eggNOG; ENOG502QV0B; Eukaryota.
DR   GeneTree; ENSGT00940000154602; -.
DR   HOGENOM; CLU_012560_8_1_1; -.
DR   InParanoid; Q63279; -.
DR   OrthoDB; 4640531at2759; -.
DR   PhylomeDB; Q63279; -.
DR   TreeFam; TF332742; -.
DR   Reactome; R-RNO-6805567; Keratinization.
DR   Reactome; R-RNO-6809371; Formation of the cornified envelope.
DR   PRO; PR:Q63279; -.
DR   Proteomes; UP000002494; Chromosome 10.
DR   Bgee; ENSRNOG00000014233; Expressed in colon and 18 other cell types or tissues.
DR   GO; GO:0016327; C:apicolateral plasma membrane; ISO:RGD.
DR   GO; GO:0071944; C:cell periphery; ISO:RGD.
DR   GO; GO:0043034; C:costamere; ISO:RGD.
DR   GO; GO:0005856; C:cytoskeleton; IBA:GO_Central.
DR   GO; GO:0016010; C:dystrophin-associated glycoprotein complex; IDA:RGD.
DR   GO; GO:0005882; C:intermediate filament; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0042383; C:sarcolemma; ISO:RGD.
DR   GO; GO:1990357; C:terminal web; ISO:RGD.
DR   GO; GO:0030018; C:Z disc; ISO:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IPI:RGD.
DR   GO; GO:0008307; F:structural constituent of muscle; ISO:RGD.
DR   GO; GO:0060706; P:cell differentiation involved in embryonic placenta development; ISO:RGD.
DR   GO; GO:0030855; P:epithelial cell differentiation; IBA:GO_Central.
DR   GO; GO:0045109; P:intermediate filament organization; IBA:GO_Central.
DR   GO; GO:0007219; P:Notch signaling pathway; ISO:RGD.
DR   GO; GO:0043627; P:response to estrogen; ISO:RGD.
DR   GO; GO:0045214; P:sarcomere organization; ISO:RGD.
DR   Gene3D; 1.20.5.170; -; 1.
DR   Gene3D; 1.20.5.500; Single helix bin; 1.
DR   Gene3D; 1.20.5.1160; Vasodilator-stimulated phosphoprotein; 1.
DR   InterPro; IPR018039; IF_conserved.
DR   InterPro; IPR039008; IF_rod_dom.
DR   InterPro; IPR002957; Keratin_I.
DR   PANTHER; PTHR23239; INTERMEDIATE FILAMENT; 1.
DR   PANTHER; PTHR23239:SF14; KERATIN, TYPE I CYTOSKELETAL 19; 1.
DR   Pfam; PF00038; Filament; 1.
DR   PRINTS; PR01248; TYPE1KERATIN.
DR   SMART; SM01391; Filament; 1.
DR   SUPFAM; SSF64593; Intermediate filament protein, coiled coil region; 2.
DR   SUPFAM; SSF46579; Prefoldin; 1.
DR   PROSITE; PS00226; IF_ROD_1; 1.
DR   PROSITE; PS51842; IF_ROD_2; 1.
PE   1: Evidence at protein level;
KW   Coiled coil; Direct protein sequencing; Intermediate filament; Keratin;
KW   Methylation; Phosphoprotein; Reference proteome.
FT   CHAIN           1..403
FT                   /note="Keratin, type I cytoskeletal 19"
FT                   /id="PRO_0000063674"
FT   DOMAIN          83..394
FT                   /note="IF rod"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01188"
FT   REGION          1..82
FT                   /note="Head"
FT   REGION          83..118
FT                   /note="Coil 1A"
FT   REGION          119..136
FT                   /note="Linker 1"
FT   REGION          137..228
FT                   /note="Coil 1B"
FT   REGION          229..251
FT                   /note="Linker 12"
FT   REGION          247..393
FT                   /note="Necessary for interaction with PNN"
FT                   /evidence="ECO:0000250"
FT   REGION          252..390
FT                   /note="Coil 2"
FT   REGION          391..403
FT                   /note="Rod-like helical tail"
FT   SITE            270
FT                   /note="Stutter"
FT   SITE            330
FT                   /note="Stutter"
FT   MOD_RES         7
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:P08727"
FT   MOD_RES         14
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P08727"
FT   MOD_RES         24
FT                   /note="Asymmetric dimethylarginine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P08727"
FT   MOD_RES         24
FT                   /note="Omega-N-methylarginine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P08727"
FT   MOD_RES         27
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         32
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:P08727"
FT   MOD_RES         35
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         40
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         43
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:P08727"
FT   MOD_RES         51
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:P08727"
FT   MOD_RES         57
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         67
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         326
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P08727"
FT   MOD_RES         394
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P08727"
FT   MOD_RES         398
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P08727"
FT   CONFLICT        143
FT                   /note="K -> N (in Ref. 5; CAA57205)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        168
FT                   /note="F -> L (in Ref. 5; CAA57205)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        177
FT                   /note="A -> G (in Ref. 5; CAA57205)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        248
FT                   /note="L -> H (in Ref. 5; CAA57205)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        265..266
FT                   /note="KN -> MD (in Ref. 5; CAA57205)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        274..280
FT                   /note="YLTQIDE -> LLKIDET (in Ref. 5; CAA57205)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        303
FT                   /note="R -> E (in Ref. 5; CAA57205)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        364..365
FT                   /note="QE -> HQ (in Ref. 5; CAA57205)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   403 AA;  44636 MW;  8D8E4ED8109EE158 CRC64;
     MTSYSYRQSS AMSSYGGMGG GPVRFGSGGV FRAPSIHGGS GGRGVSVSST RIVSSSSGGY
     VGGRGGSFSG ALTVTDGLLG GNEKITMQNL NDRLASYLDK VRALEQANGE LEVKIRDWYQ
     KQGPGPFRDY SQYFKTIEDL RDKILGATIE NSKIVLQIDN ARLAADDFRT KFETEQALRM
     SVEADINGLR RVLDELTLAR TDLEMQIENL KEELAYLKKN HEEEISALRS QVGGQVSVEV
     DSTPGIDLAK ILSEMRSQYE AMAEKNRKDA EAWYLTQIDE LNTQVAVHTT QIQINKTEVT
     ELRRKVQDLE IELQSQLSMK AALEGTVAEI EARYGAQLSH IQGVISSIEV QLSNVRADTE
     RQNQEYQQLM DIKSRLEQEI ATYRSLLEGQ EAHYNSLSIA KAL
//
